Search research articles
Contact Us
Filters
Showing results (41-50 of 182) with videos related to
Page
of 19
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
April 27, 2024
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
Arnaud Bourdin, Geoffrey Chupp, David J Jackson, et al.
Drug Safety
|
April 4, 2020
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
David J Jackson, Stephanie Korn, Sameer K Mathur, et al.
Allergy
|
August 1, 2024
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W Busse, Peter H Howarth, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 3, 2022
The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti-IL-5R treatment
Andrew P Hearn, Michelle S Mak, Irilda Budaj, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
Renaud Louis, Marek Lommatzsch, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 7, 2025
Systematic Literature Review of Real-World Outcomes of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
David J Jackson, Anat Shavit, Ning Ding, et al.
ERJ Open Research
|
February 4, 2020
Inflammatory and microbiological associations with near-fatal asthma requiring extracorporeal membrane oxygenation
Sunil Patel, Neeraj M Shah, Akanksha M Malhotra, et al.
Chest
|
May 23, 2025
Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL5/5R Therapy
Alexandra M Nanzer, Jessica Gates, Faizan Haris, et al.
Systematic Reviews
|
March 12, 2026
Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA)
Lisa Nwankwo, Ian Maidment, Jimstan Periselneris, et al.
ERJ Open Research
|
January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Brian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 182) with videos related to
Sort By:
Page
of 19
The Journal of Allergy and Clinical Immunology. in Practice
|
April 27, 2024
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
Arnaud Bourdin, Geoffrey Chupp, David J Jackson, et al.
Drug Safety
|
April 4, 2020
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
David J Jackson, Stephanie Korn, Sameer K Mathur, et al.
Allergy
|
August 1, 2024
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W Busse, Peter H Howarth, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 3, 2022
The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti-IL-5R treatment
Andrew P Hearn, Michelle S Mak, Irilda Budaj, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
Renaud Louis, Marek Lommatzsch, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 7, 2025
Systematic Literature Review of Real-World Outcomes of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
David J Jackson, Anat Shavit, Ning Ding, et al.
ERJ Open Research
|
February 4, 2020
Inflammatory and microbiological associations with near-fatal asthma requiring extracorporeal membrane oxygenation
Sunil Patel, Neeraj M Shah, Akanksha M Malhotra, et al.
Chest
|
May 23, 2025
Tezepelumab in Patients With Eosinophilic Granulomatosis With Polyangiitis After Suboptimal Response to Anti-IL5/5R Therapy
Alexandra M Nanzer, Jessica Gates, Faizan Haris, et al.
Systematic Reviews
|
March 12, 2026
Protocol for a systematic literature review and network meta-analysis of the evidence for therapies in allergic bronchopulmonary aspergillosis (ABPA)
Lisa Nwankwo, Ian Maidment, Jimstan Periselneris, et al.
ERJ Open Research
|
January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Brian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
Page
of 19